Finch Therapeutics Group (FNCH) Stock Chart & Stock Price History $13.00 -0.08 (-0.57%) As of 07/7/2025 11:45 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Finch Therapeutics Group Stock Price Performance The Finch Therapeutics Group (FNCH) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 870.15%, with a year-to-date return of 15.04%. In the past month, the stock has decreased 2.89%, reflecting recent market activity. As of the latest close, Finch Therapeutics Group traded at $13.00 with a market cap of $20.88 million and volume of 1,766 shares. Receive FNCH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.57%1 Month Performance-2.89%3 Month Performance+0.54%Year-To-Date Performance+15.04%1 Year Performance+870.15% FNCH Stock Chart for Wednesday, July, 9, 2025 FNCH Chart by TradingView Finch Therapeutics Group Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/08/2025$13.00$13.00$13.20$13.001,766 shs$20.88 million07/07/2025$13.08$13.00-0.57%$13.20$13.001,766 shs$21.00 million07/04/2025$13.08$13.08$13.08$13.08509 shs$21.00 million07/03/2025$13.20$13.08-0.95%$13.08$13.08509 shs$21.00 million07/02/2025$13.20$13.20$13.20$13.2046 shs$21.20 million07/01/2025$13.20$13.20$13.20$13.2017 shs$21.20 million06/30/2025$13.20$13.20$13.20$13.2045 shs$21.20 million06/27/2025$13.20$13.20$13.20$12.894,899 shs$21.20 million06/26/2025$13.00$13.20+1.54%$13.20$12.894,899 shs$21.20 million06/25/2025$13.00$13.00$13.15$13.001,271 shs$20.88 million Get the Latest News and Ratings for FNCH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. 06/24/2025$13.01$13.00-0.08%$13.15$13.001,271 shs$20.88 million06/23/2025$13.45$13.01-3.27%$13.35$13.01806 shs$20.89 million06/20/2025$13.43$13.45+0.13%$13.45$13.003,351 shs$21.60 million06/19/2025$13.43$13.43$13.43$13.401,877 shs$21.57 million06/18/2025$13.60$13.43-1.24%$13.43$13.401,877 shs$21.57 million06/17/2025$13.60$13.60$13.60$13.60629 shs$21.84 million06/16/2025$13.75$13.60-1.09%$13.60$13.601,521 shs$21.84 million06/13/2025$12.88$13.75+6.75%$13.75$13.75402 shs$22.08 million06/12/2025$13.70$12.88-5.99%$13.75$12.88828 shs$20.69 million06/11/2025$13.39$13.70+2.33%$13.70$13.651,346 shs$22.00 million06/10/2025$13.39$13.39$13.57$13.39677 shs$21.50 million06/09/2025$13.57$13.39-1.33%$13.57$13.39677 shs$21.50 million Related Companies CHRS Stock Price Chart CLLS Stock Price Chart CRBP Stock Price Chart CLYM Stock Price Chart ZNTL Stock Price Chart JSPR Stock Price Chart EXOZ Stock Price Chart TCRX Stock Price Chart ELUT Stock Price Chart VNRX Stock Price Chart Receive FNCH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FNCH) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Finch Therapeutics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Finch Therapeutics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
